Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
2,318.40
-1.60 (-0.07%)
Aug 14, 2026, 3:14 PM IST
Glenmark Pharmaceuticals Employees
Glenmark Pharmaceuticals had 15,800 employees as of March 31, 2025. The number of employees increased by 811 or 5.41% compared to the previous year.
Employees
15,800
Change (1Y)
811
Growth (1Y)
5.41%
Revenue / Employee
11.23M INR
Profits / Employee
1.14M INR
Market Cap
654.25B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 15,800 | 811 | 5.41% |
| Mar 31, 2024 | 14,989 | -567 | -3.64% |
| Mar 31, 2023 | 15,556 | 141 | 0.91% |
| Mar 31, 2022 | 15,415 | 4,451 | 40.60% |
| Mar 31, 2021 | 10,964 | 297 | 2.78% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cipla | 31,369 |
| Zydus Lifesciences | 29,980 |
| Aurobindo Pharma | 29,209 |
| Mankind Pharma | 20,451 |
| Alkem Laboratories | 19,346 |
| Ipca Laboratories | 17,210 |
| Ajanta Pharma | 9,628 |
| Laurus Labs | 7,059 |
Glenmark Pharmaceuticals News
- 12 days ago - Glenmark Pharmaceuticals Transcript: Q1 26/27 - Transcripts
- 12 days ago - Glenmark Pharmaceuticals Quarterly report: Q1 2027 - Filings
- 12 days ago - Glenmark Pharmaceuticals Slides: Q1 2027 - Filings
- 15 days ago - India's Glenmark Pharma posts higher quarterly profit on strong demand - Reuters
- 5 weeks ago - Pharma sector stocks today, July 6: Panacea Biotec surges 2.47%, Ajanta Pharma gains 1.48%, Glenmark Pharma up 1.29% - Business Upturn
- 5 weeks ago - Glenmark Pharmaceuticals launches Olanzapine injection equivalent to Zyprexa - Business Upturn
- 6 weeks ago - Pharma sector stocks today, July 2: Alembic Pharma falls 1.88%, Glenmark Pharma jumps 0.91%, Sun Pharma gains 0.67% - Business Upturn
- 6 weeks ago - Glenmark Pharmaceuticals receives six observations from U.S. FDA inspection at Goa facility - Business Upturn